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Neutrophils deposit antimicrobial proteins, such as myeloperoxidase and proteases on 
chromatin, which they release as neutrophil extracellular traps (NETs). Neutrophils also 
carry key components of the complement alternative pathway (AP) such as properdin 
or complement factor P (CFP), complement factor B (CFB), and C3. However, the 
contribution of these complement components and complement activation during NET 
formation in the presence and absence of bacteria is poorly understood. We studied 
complement activation on NETs and a Gram-negative opportunistic bacterial pathogen 
Pseudomonas aeruginosa (PA01, PAKwt, and PAKgfp). Here, we show that anaphyla-
toxin C5a, formyl-methionyl-leucyl-phenylalanine (fMLP) and phorbol myristate acetate 
(PMA), which activates NADPH oxidase, induce the release of CFP, CFB, and C3 from 
neutrophils. In response to PMA or P. aeruginosa, neutrophils secrete CFP, deposit it 
on NETs and bacteria, and induce the formation of terminal complement complexes 
(C5b–9). A blocking anti-CFP antibody inhibited AP-mediated but not non-AP-mediated 
complement activation on NETs and P. aeruginosa. Therefore, NET-mediated comple-
ment activation occurs via both AP- and non AP-based mechanisms, and AP-mediated 
complement activation during NETosis is dependent on CFP. These findings suggest 
that neutrophils could use their “AP tool kit” to readily activate complement on NETs and 
Gram-negative bacteria, such as P. aeruginosa, whereas additional components present 
in the serum help to fix non-AP-mediated complement both on NETs and bacteria. This 
unique mechanism may play important roles in host defense and help to explain specific 
roles of complement activation in NET-related diseases.
Keywords: neutrophil extracellular traps, neTosis, complement system, alternative pathway, properdin, 
Pseudomonas aeruginosa
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inTrODUcTiOn
Neutrophils play a central role in the innate immune system and 
function in inflammation and immune surveillance. At sites of 
inflammation, neutrophils kill pathogens via phagocytosis and 
release of proteolytic enzymes (1, 2). Recently, the ability of neu-
trophils to form web-like neutrophil extracellular traps (NETs) 
has been identified as an additional strategy for antimicrobial 
defense. The process of NET formation (i.e., NETosis) is a specific 
form of cell death, in which nuclear DNA undergoes decondensa-
tion with subsequent expulsion of chromatin that is coated with 
cytotoxic granular proteins, such as myeloperoxidase (MPO), 
elastase, and other proteases (3). NETs are released in response 
to a variety of stimuli, including NADPH oxidase (Nox) agonist, 
such as phorbol-12-myristate-13-acetate (PMA), inflammatory 
stimuli, and bacteria (4, 5). Two major types of NETosis have been 
reported to date: Nox-dependent NETosis and Nox-independent 
NETosis, in which reactive oxygen species (ROS) are generated 
by Nox and mitochondrial complexes, respectively (6–9). In both 
of these types of NETosis, neutrophil release chromatin coated 
with granular proteins as NETs. In the presence of C5a, GM-CSF-
primed neutrophils undergo a vital NETosis, in which cells do 
not die, but release mitochondrial DNA. This type of NETosis is 
regulated by mitochondrial ROS production (10).
Once formed, NETs ensnare pathogens and expose them to 
high localized concentrations of antimicrobial proteins (11). 
NETs can also be cytotoxic and have been shown to contribute to 
thrombosis, sepsis, cystic fibrosis, asthma, systemic lupus erythe-
matosus (SLE), rheumatoid arthritis (RA), and anti-neutrophil 
cytoplasmic antibody (ANCA)-associated vasculitis (AAV) 
(12–24). Complement and infections have been implicated in 
the pathogenesis and exacerbation of many of these diseases. 
Although it has recently been described that NETs can activate 
and deposit complement alternative pathway (AP) components 
(25), the involvement of the different complement pathways and 
their components in the context of NETosis and bacterial infec-
tion has not been fully understood. This fundamental knowledge 
is essential for understanding molecular mechanisms involved in 
NET-related pathobiology.
The complement system consists of more than 30 proteins 
distributed in the circulation and on endothelial cells, and func-
tions primarily in microbial defense and clearance of immune 
complexes and injured cells (26). Complement can be constantly 
active (via the complement AP) or become activated by immune 
complexes and dying cells [via the C1q-mediated classical pathway 
(CP)] or carbohydrate ligands on microorganisms [via the lectin 
pathway (LP)] (26). Complement factor P (CFP), the only posi-
tive complement regulator, acts as stabilizer of the AP convertase 
(C3bBbP) and selective pattern recognition molecule of certain 
microorganisms and host cells (i.e., apoptotic/necrotic cells) by 
serving as a platform for the assembly of the AP C3 convertase 
(27). Complement progression includes the activation of comple-
ment proteins C3 and C5 (to form the potent anaphylatoxins C3a 
and C5a and the opsonins C3b and C5b) and the subsequent 
activation of the terminal pathway with the formation of the 
potentially lytic membrane attack complex (MAC), C5b–9. AP 
activation is critically enhanced by the C3 convertase C3bBbP, 
and requires tight regulation to maintain the balance between 
necessary activation and harmful over-activation (26). Bacteria 
are capable of inducing Nox-dependent NETosis (9, 28–30), and 
we aimed to identify possible links between NETosis, bacteria, 
and the complement system, in particular, the possibility that 
neutrophils mount a targeted complement response to infectious 
agents via the formation of NETs and deposition of complement 
components on NETs and microbial pathogens.
MaTerials anD MeThODs
ethics
Informed written consent was obtained from all donors. The 
study protocol was approved by the Research Ethics Board at The 
Hospital for Sick Children, Toronto, ON, Canada.
reagents
All buffer salts and reagents were obtained from Sigma-Aldrich 
(St. Louis, MO, USA) unless stated otherwise.
Bacterial culture
Pseudomonas aeruginosa (mPA01, PAKwt, and PAKgfp) cultures 
were grown overnight in LB-broth. PAKgfp was maintained in 
30 μg/ml gentamicin. The concentration of bacteria was calculated 
using [CFU] × 108 = (OD600) 30.88 − 99,607. For NETosis assays, 
P. aeruginosa sub-cultured for 3 h was used at a multiplicity of 
infection (MOI) of 10 or 100.
neutrophil isolation and Preparation  
of neutrophil lysates
Human peripheral neutrophils were purified from whole blood 
(20 ml) collected in BD EDTA-vacutainers from healthy donors 
using Polymorphprep™ (Axis-shield, Oslo, Norway). After 
lysing erythrocytes with hypotonic buffer, neutrophils were 
resuspended in RPMI 1640 (Wisent Bioproducts, Montreal, 
QC, Canada) (31). To obtain neutrophil lysate, cell pellets were 
resuspended in a lysis buffer [1% (v/v) Triton X-100, 50  mM 
Tris, pH 7.4, 10 mM KCl containing 2× complete, mini protease 
inhibitor cocktail (Roche Diagnostics, Laval, QC, Canada) 
supplemented with 0.5  mM EDTA, 25 μM leupeptin, 25 μM 
pepstatin, 25 μM aprotinin, 1 mM levamisole, 1 mM Na3VO4, 
25  mM NaF, 1  mM PMSF], sonicated (VWR Sonics model 
50D), and incubated for 15 min at 4°C. Neutrophil lysates were 
centrifuged at 25,000× g for 30 min at 4°C and stored at −80°C 
for future analysis.
neutrophil activation, Oxidative Burst,  
and secretion
Neutrophils (2 × 107 cells/ml) were resuspended in RPMI 1640 
with 10 mM Hepes, pH 7.4, and activated with C5a (CompTech, 
Tyler, TX, USA) (1 μM), formyl-methionyl-leucyl-phenylalanine 
(fMLP) (1 μM) or PMA (20 nM), and incubated [37°C, 5% (v/v) 
CO2] for 30  min. Stimulation was terminated by incubating 
these cells at 4°C for 5 min. Neutrophils were pelleted (1000× g 
for 10  min) and the supernatant was collected and further 
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centrifuged at 25,000× g for 10 min at 4°C, immediately placed 
in 2× neutrophil Laemmli sample buffer, heated at 95°C for 5 min 
and stored at −80°C for future analysis. Neutrophil lysates were 
prepared from the remaining cell pellet as described in the Section 
“Neutrophil Isolation and Preparation of Neutrophil Lysates.” To 
determine respiratory burst, neutrophils (1 × 106 cells/ml) were 
pre-loaded with dihydrorhodamine (DHR) 123 (10 μM), treated 
with the agonists as above and analyzed by flow cytometry 
(Gallios, Beckman Coulter, Mississauga, ON, Canada). Cells were 
first gated with forward and side scatters, and further gated for 
Hoechst (1 μg/ml) using 405/450 BP 40 filter channel. ROS was 
detected using 488/429 BP 28.25 filter channel.
sytox green Plate reader assay
Neutrophils (3 ×  104  cells) were seeded onto 96-well plates in 
the presence of cell-impermeable Sytox Green DNA-binding dye 
(5 μM) and were activated with agonists or three stains of P. aer-
uginosa (mPAO1, PAKwt, and PAKgfp) at MOIs of 10 and 100. 
For inhibition studies, neutrophils were preincubated with 2 μM 
of Nox inhibitor, diphenyleneiodonium (DPI) for 1 h before acti-
vation. Fluorescence intensity was measured by the POLARstar 
Omega microplate reader (BMG Labtech, Ortenberg, Germany) 
with excitation/emission (485/520), every 30 min. NET formation 
was normalized to total neutrophils DNA content determined by 
permeabilizing the cells with 0.5% (w/v) Triton X-100.
Western Blot
Neutrophil lysates (50 μg) were size-fractionated in 10% (w/v) 
SDS-polyacrylamide gels, transferred to nitrocellulose mem-
branes, blocked with 5% (w/v) skim-milk + 0.05% (v/v) Tween-
20 (TBST), probed with goat polyclonal antibody to complement 
proteins (1:1000 dilution; Complement Technology, Tyler, TX, 
USA) or mouse monoclonal antibody to β-actin (BA3R, 1:10,000 
dilution; Thermo Fisher Scientific, Rockford, IL, USA) in 5% 
(w/v) skim-milk in TBST, washed, and incubated with secondary 
antibody in 5% (w/v) skim-milk in TBST. Proteins were detected 
using Western Lighting™ Plus-ECL, Enhanced (PerkinElmer, 
Waltham, MA, USA) and developed on radiographic film on a 
Kodak X-Omat 2000a processor.
Detection of complement Proteins in neTs
Phorbol-12-myristate-13-acetate (20  nM) activated neutrophils 
at 240 min were fixed with 4% (w/v) paraformaldehyde (Electron 
Microscopy Sciences, Fort Washington, PA, USA), blocked with 
3% (v/v) cold water fish skin gelatin and incubated with anti-com-
plement antibodies: rabbit polyclonal antibody to CFP (SC-68366, 
1:50 dilution; Santa Cruz Biotechnology, Dallas, TX, USA), rabbit 
polyclonal antibody to complement factor B (CFB) (SC-67151, 
1:50 dilution; Santa Cruz Biotechnology, Dallas, TX, USA), and 
rabbit polyclonal antibody to complement C3 (ab97462, 1:100 
dilution; Abcam, Cambridge, MA, USA). Neutrophils activated 
with PMA were co-stained with mouse monoclonal antibody to 
MPO (ab25989, 1:500 dilution; Abcam, Cambridge, MA, USA). 
Complexes were detected with donkey anti-primary antibodies 
conjugated with Alexa Fluor® 555 (Invitrogen, Eugene, OR, USA). 
Specimens were mounted with Dako Fluorescence Mounting 
Media (Dako Canada, Burlington, ON, Canada) for analysis with 
spinning-disk confocal microscopy.
c5b–9 Formation on neTs
After 240  min of neutrophil activation, culture plates were 
centrifuged at 200× g for 5 min at 4°C. The media was replaced 
with 500 μl of 20% (v/v) Refludan® (Bayer Healthcare, Wayne, 
NJ, USA) fresh frozen PPP prepared in RPMI 1640 media or 
AP buffer (20 mM Hepes, pH 7.4, 144 mM NaCl, 7 mM MgCl2, 
and 10  mM EGTA). For experiments with AP buffer, a buffer 
exchange was performed prior to the addition of plasma (Bayer 
Healthcare, Wayne, NJ, USA). After 15  min [37°C, 5% (v/v) 
CO2], specimens were fixed with 4% (w/v) paraformaldehyde 
(Electron Microscopy Sciences, Fort Washington, PA, USA). In 
some experiments, DNase I (50 μg/ml) was added to digest DNA. 
After blocking with 3% (v/v) gelatin, mouse monoclonal antibody 
to C5b–9 (DIA 011-01, 1:200 dilution; Antibody Shop, Gentofte, 
Denmark) was incubated, washed, and further incubated with 
donkey anti-mouse secondary antibody conjugated with Alexa 
Fluor® 555 (Invitrogen, Eugene, OR, USA). PAKgfp signal was 
enhanced with Alexa Fluor® 488 conjugated rabbit polyclonal 
antibody to GFP (A21311, 1:400 dilution; Invitrogen, Eugene, 
OR, USA). For CFP inhibitor assays, optimal concentration of a 
mouse monoclonal anti-CFP antibody (Anti Factor P#1, A233; 
Quidel Corporation, San Diego, CA, USA) was determined by 
rabbit red blood cell lysis assay (32). An antibody concentration 
of 4 μg/ml was used in the final assays. Presence of C5b–9 was 
detected as described above. Wheat germ agglutinin was used for 
labeling neutrophil membrane. Specimens were mounted and 
analyzed with spinning-disk confocal microscopy.
spinning-Disk confocal Microscopy and 
colocalization analysis
Images were taken on an Olympus IX81 inverted fluorescence 
microscope using a 60×/1.35 oil immersion objective equipped 
with a Hamamatsu C9100-13 back-thinned EM-CCD camera 
and Yokogawa CSU X1 spinning-disk confocal scan head (with 
Spectral Aurora Borealis upgrade). The unit is equipped with 
four separate diode-pumped solid state laser lines (Spectral 
Applied Research, 405, 491, 561, and 642  nm) with emission 
filters: 447 ± 60, 525 ± 50, 593 ± 40, 620 ± 60, 676 ± 29, and 
700  nm ±  75, and 1.5× magnification lens (Spectral Applied 
Research). Confocal images were taken with an Improvision 
Piezo Focus Drive. Z-stacks were taken at 0.25 μm. Images taken 
using the spinning-disk confocal microscope were deconvolved 
by iterative restoration using Volocity Software (PerkinElmer, 
Waltham, MA, USA) with confidence limit set to 95% and itera-
tion limit set to 20.
statistical analysis
Student’s t-test, or one-way or two-way ANOVA with Tukey’s 
multiple comparison test was used for statistical comparison as 
needed. A p-value was set at 0.05, 0.01, or 0.001 for statistical sig-
nificance. All statistical analyses were performed using GraphPad 
Prism (GraphPad Software, La Jolla, CA, USA) statistical analysis 
software (Version 6.0).
FigUre 2 | neutrophils secrete complement proteins upon activation 
with PMa, fMlP, and c5a. Neutrophils were activated with C5a (1 μM), 
fMLP (1 μM), and PMA (20 nM) for 30 min. Cells were harvested by 
centrifugation, and the supernatant was collected to investigate for secreted 
proteins. Western blot analysis of the pellet and the supernatant reveals that 
neutrophils contain (a) CFP, (B) C3, and (c) complement factor B and 
secrete them upon activation. β-actin served as loading control.
FigUre 1 | PMa, but not c5a and fMlP, induce neT formation. Sytox Green fluorescence plate reader assay for neutrophils activated with C5a (1 or 2 μM), 
fMLP (1 or 2 μM), and PMA (20 nM) reveals NET formation only after stimulation with PMA. Diphenyleneiodonium (DPI), a NADPH oxidase inhibitor, blocks 
PMA-induced NET formation. Data are presented as mean ± SEM from three to seven individual experiments. Fluorescence emission of Sytox Green was 
normalized to total DNA of resting neutrophils permeabilized with 0.5% (v/v) triton X-100. Statistical significance was obtained by comparing to SYTOX fluorescence 
from resting neutrophils. Two-way ANOVA with Tukey’s multiple comparison test, $p < 0.0001.
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resUlTs
PMa, but not fMlP and c5a, induces 
neTosis
Reactive oxygen species is considered to be important for 
NETosis. However, different agonists induce ROS to dif-
ferent degrees. Therefore, to determine whether ROS was 
sufficient to induce NETosis, ROS production was measured 
30 min post neutrophil stimulation using DHR 123 and flow 
cytometry. C5a (1–2 μM) did not generate ROS above base-
line levels (Figure S1A in Supplementary Material); however, 
similar concentrations of fMLP led to a 1.5-fold increase in 
ROS compared to baseline values (p <  0.05; Figure S1B in 
Supplementary Material). The use of 20 nM PMA produced a 
ninefold increase of ROS in comparison to non-treated control 
neutrophils (p < 0.05; Figure S1C in Supplementary Material). 
The overall ability of these agonists to induce ROS production 
was PMA >> fMLP > C5a.
Although both PMA and fMLP induced ROS production, 
whether fMLP can induce NETosis is uncertain. Therefore, to 
identify the ability of PMA, fMLP, and C5a to independently 
elicit NETosis, we treated neutrophils with varying concentra-
tions of these reagents. NETosis was monitored using a plate 
reader assay by measuring the production of extracellular DNA. 
This assay monitors the fluorescence generated by the binding 
of cell-impermeable DNA-binding Sytox Green fluorescent dye 
to NET DNA. Neither C5a nor fMLP (up to concentration of 
2  μM) induced NET formation within the observed 300-min 
time period (Figure 1). However, stimulation of neutrophils with 
PMA resulted in NET generation after approximately 120 min, 
as determined by Sytox Green plate reader assay (Figure  1) 
and nuclear morphology changes (Figure S2 in Supplementary 
Material). As expected, the use of the NADPH inhibitor DPI 
abrogated PMA-induced NET formation with levels remaining 
near baseline. This confirms that PMA induces NETosis via the 
Nox-dependent pathway, and that C5a and fMLP on their own 
do not induce NETosis.
induction of neTosis causes release  
of complement Factors
To identify whether stimulation of neutrophils results in the release 
of complement factors, Western blot analysis was performed on 
the cell pellets and cell-free supernatant (Figure 2). Protein levels 
of the complement proteins CFP, C3, and CFB were compared 
for neutrophils induced for 30 min either with C5a, fMLP, and 
PMA or with buffer. Complement proteins were not detected 
in the supernatant of non-activated neutrophils, with proteins 
being identified exclusively in cell pellet samples. The release of 
all three complement proteins was observed for all induction 
FigUre 3 | complement factor P deposits on PMa-induced neTs. Spinning-disk immunofluorescence microscopy images show that (a) complement 
proteins, e.g., CFP (red), are found to associate with cell body, and NETs induced by PMA. NETs were visualized using (B) an anti-MPO antibody (green) and  
(c) DAPI stain for DNA (blue). (D) Merged image shows relative locations of proteins on cell body and NETs. Images were taken using a 60×/1.35 oil immersion 
objective. Scale bar, 9.00 μm.
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Deposition pattern of both MPO and CFP shows substantial over-
lap throughout the extracellular DNA lattice structure. Therefore, 
neutrophils deposit CFP on NETs.
PMa-induced neTs activate complement
In order to analyze whether complement activation occurs on NETs, 
neutrophils were stimulated with PMA, washed and incubated 
with 20% complement active plasma for 15 min in complement 
competent buffers. Under these conditions, both AP- and non-AP-
mediated complement fixation can occur. Immunofluorescence 
microscopy was performed on these NETs to identify the deposition 
of terminal complement complex C5b–9. Images show that C5b–9 
deposits on NETs (Figures 4 and 5 – middle column; Figures 4H 
and 5H with 2× magnified insets of representative areas). The use of 
DNAse I, which removes pre-formed NETs, causes a large decrease 
in the detection of C5b–9 deposition. These data suggest that the 
presence of NETs is necessary to activate complement cascade and 
deposit terminal complement complex.
methods; however, the use of PMA elicited the greatest release 
of both CFP and CFB within the supernatant (Figures 2A–C). 
Pelleted samples for activated cells also contained a large amount 
of complement proteins: primarily CFP and CFB (and its activa-
tion product Bb). Furthermore, CFB-Bb was only identified in 
PMA-induced neutrophils (Figure 2C). These results indicate the 
capability of PMA to not only induce NETosis but also cause the 
greatest release of complement proteins in comparison to C5a 
and fMLP.
PMa-induced neTosis Deposits  
cFP on neTs
As the next step, we sought to identify whether CFP was capable of 
adhering to NETosing neutrophils and NETs. Immunofluorescence 
analysis performed on PMA-induced NETs showed the deposition 
of both CFP and MPO (another known NET-associated protein) 
on the surface of extracellular NETs (Figure 3). CFP could also 
be detected on the neutrophil membranes after NET formation. 
FigUre 4 | PMa-induced neTs activate complement to form c5b–9. Neutrophils were left untreated (a,D,g), activated with 20 nM PMA (B,e,h), and treated 
with DNase I after PMA activation to disseminate the formation of NETs (c,F,i). After induction of NETosis in RPMI buffer, 20% (v/v) autologous plasma was added. 
(a–c) NETs were visualized with DAPI. (D–F) C5b–9 was detected using mouse monoclonal antibody to C5b–9. Image was taken with 60×/1.35 oil immersion 
objective. (h) with 2× magnified inset of representative area. Scale bar, 9.00 μm.
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PMa-induced neTosis activates 
complement also via alternative Pathway
To further identify the contribution of AP to NETosis, this experi-
ment was repeated except that the plasma incubation step was 
performed in the presence of AP buffer allowing for AP activation 
only. Immunofluorescence microscopy images show that C5b–9 
could be deposited via AP (Figure 6; Figures 6I–K with 2× mag-
nified insets of representative areas). To determine whether block-
ing CFP is sufficient to prevent complement activation, 4 μg/ml 
anti-CFP antibody was added during complement activation. 
This antibody concentration was chosen because AP-dependent 
rabbit erythrocyte hemolysis was inhibited in the presence 
of >4  μg/ml anti-CFP antibody (Figure S3 in Supplementary 
Material). Immunofluorescence microscopy reveals that blocking 
CFP fully prevents C5b–9 deposition in AP buffer conditions, but 
reduced C5b–9 deposition only slightly in complete buffer con-
ditions (Figure  6). Therefore, both AP- and non-AP-mediated 
complement depositions occur on NETs induced by PMA.
P. aeruginosa-induced neTosis Deposits 
cFP on neTs and Bacteria
To test the ability of complement fixation on pathogens dur-
ing NETosis, neutrophils were exposed to various strains of 
P. aeruginosa (mPA01, PAKwt, and PAKgfp). Similar to the 
PMA experiments described above, NETosis was monitored 
using Sytox Green plate reader assays. All three strains of these 
bacteria induced NETosis, and followed similar kinetics in terms 
of post-infection time response (Figure  7). NETosis began at 
FigUre 5 | PMa-induced neTs activate complement alternative pathway to form c5b–9. Neutrophils were left untreated (a,D,g), activated with 20 nM 
PMA (B,e,h), and treated with DNase I to disseminate the formation of NETs (c,F,i). A buffer exchange was performed with three washes of PBS and one wash of 
AP buffer, followed by addition of 20% (v/v) autologous plasma in AP buffer. (a–c) NETs were visualized with DAPI. (D–F) C5b–9 was detected using mouse 
monoclonal antibody to C5b–9. Image was taken with 60×/1.35 oil immersion objective. (h) with 2× magnified inset of representative area. Scale bar, 9.00 μm.
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approximately 120 min and continued to increase throughout the 
300-min experimental time period. Furthermore, this induction 
is bacterial load dependent with both a faster response and a larger 
response observed when the MOI was increased from 10 to 100. 
To determine whether this NETosis induction was dependent 
on Nox, DPI was included in the media. Nox inhibitor DPI fully 
abrogated P. aeruginosa-induced NETosis for all three stains at 
both MOIs (p < 0.05). This finding indicates that similar to PMA, 
bacteria-induced NETosis occurs in a Nox-dependent manner.
To determine CFP deposition during NETosis, specimens 
were immunostained. In the absence of serum, CFP was detected 
on both bacteria and NETs, and DNAse I treatment abolished 
CFP deposition (Figure  8; Figure  8K with 2× magnified inset 
of a representative area). These results indicate that during P. 
aeruginosa-induced NETosis CFP is released from the neutrophils 
and deposits on NETs and bacteria.
P. aeruginosa-induced neTosis activates 
complement on neTs
To determine whether NET induction mediated by P. aeruginosa 
results in complement activation, C5b–9 deposition was deter-
mined by immunofluorescence microscopy. Images show that 
C5b–9 was deposited on NETs (Figure 9; Figure 9K with a 2× 
magnified inset of a representative area). This effect was abolished 
when the NET DNA lattice was removed by DNAse treatment. 
Thus, complement deposits on NETs during NETosis.
P. aeruginosa-induced neTosis also 
activates complement via alternative 
Pathway
To determine whether the AP is involved in P. aeruginosa-
induced NETosis and C5b–9 formation, we first examined C5b–9 
FigUre 6 | anti-cFP antibody blocks activation of complement aP to form c5b–9 on PMa-induced neTs. Neutrophils were activated with PMA (20 nM) 
to induce NET formation. Plasma with RPMI buffer was used to activate all complement pathways, AP buffer to only activate the alternative pathway. A monoclonal 
anti-properdin antibody was used to inhibit AP activation. A buffer exchange was performed followed by addition of 20% (v/v) plasma:RPMI1640 + 10 mM Hepes 
[far left column (a,e,i)], 20% (v/v) plasma:RPMI1640 + 10 mM Hepes + mAb properdin [left column (B,F,J)], 20% (v/v) plasma:AP buffer [right column (c,g,K)], 
20% (v/v) plasma:AP buffer + mAb properdin [far right column (D,h,l)]. (a–D) show DAPI, (e–h) C5b–9 deposition, and (i–l) merged images. Images were taken 
with 60×/1.35 oil immersion objective. (i–K) with 2× magnified insets of representative areas. Scale bar, 9.00 μm.
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FigUre 7 | P. aeruginosa induces nox-dependent neTosis. Sytox Green plate reader assay showing the NETosis ability of different strains of P. aeruginosa 
(mPAO1, PAKwt, and PAKgfp). Fluorescence emission of Sytox green was normalized to total DNA of resting neutrophils permeabilized with 0.5% triton X-100. Nox 
inhibitor DPI suppresses the NETosis of all three strains. Data are presented as mean ± SEM from four to seven individual experiments. Statistical significance 
compared to Sytox fluorescence from resting neutrophils. 1 denotes statistical significance between different multiplicities of infection. Two-way ANOVA with Tukey’s 
multiple comparison test, *p < 0.05, **p < 0.01, #p < 0.001, $p < 0.0001.
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FigUre 8 | cFP binds bacteria and neTs during P. aeruginosa-induced neTosis. Neutrophils were activated in the absence of serum with PAKgfp for 30 min 
(a,D,g,J), 240 min (B,e,h,K), and 240 min with DNase I (c,F,i,l). Neutrophil CFP [(g–i); red] binds to PAKgfp [(D–F); green]. Merged images (J–l). Representative 
images from one of three independent experiments are shown. Confocal images were taken with a 60×/1.35 oil immersion objective. (K) with 2× magnified inset of 
a representative area. Scale bar, 9.00 μm.
deposition under AP activation conditions. Immunofluorescence 
microscopy analysis shows that C5b–9 is deposited on NETs 
(Figure 10; Figure 10K with a 2× magnified inset of a representa-
tive area).
Next, we used anti-CFP antibody to test the importance of 
CFP under AP activation conditions (Figure S3 in Supplementary 
Material). Induction of NETosis was performed using PAKgfp 
at an MOI of 100. After NET induction with PAKgfp, samples 
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were maintained in complement competent RPMI media with 
the addition of 20% (v/v) autologous plasma (Figure 11 – first 
column; Figure  11M with a 2× magnified inset of a repre-
sentative area). The addition of anti-CFP antibody to these 
samples did not change the formation and deposition of C5b–9 
(Figure 11 – second column; Figure 11N with a 2× magnified 
inset of a representative area). Next, we incubated neutrophils with 
20% (v/v) plasma in AP buffer. C5b–9 deposition was detected on 
NETs (Figure 11 – third column; Figure 11O with a 2× magnified 
inset of a representative area). Adding 4 μg/ml anti-CFP antibody 
FigUre 9 | c5b–9 deposits on P. aeruginosa-induced neTs. Neutrophils untreated (a,D,g,J), activated with PAKgfp (B,e,h,K) in the presence of DNase I 
(c,F,i,l). Addition of 20% (v/v) autologous plasma to NETs [(a–c); DAPI, blue] leads to deposition of C5b–9 [(g–i); red] onto NETs [(J–l); merged], but not PAKgfp 
[(D–F); green]. Representative image from three independent experiments taken with 60×/1.35 oil immersion objective is shown. (K) with a 2× magnified inset of a 
representative area. Scale bar, 9.00 μm.
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FigUre 10 | c5b–9 deposits on P. aeruginosa-induced neTs via aP. Neutrophils were left untreated (a,D,g,J), activated with PAKgfp (B,e,h,K), and treated 
with DNase I. A buffer exchange was performed, followed by addition of 20% (v/v) autologous plasma in AP buffer. NETs were visualized with (a–c) DAPI, and 
immunostained for [(D–F); green] GFP, [(g–i); red], and [(J–l); merged] C5b–9. Images were taken with 60×/1.35 oil immersion objective. (K) with a 2× magnified 
inset of a representative area. Scale bar, 9.00 μm.
before incubating bacteria-induced NETs with plasma inhibited 
C5b–9 deposition on NETs (Figure 11 – fourth column). Taken 
together, these data show that complement activation and pro-
gression to C5b–9 formation on NETs occurs via AP and non-AP 
pathways, and that AP activation depends on CFP.
DiscUssiOn
Over the past decade, the ability of neutrophils to generate NETs 
has led to studies attempting to determine their function and 
involvement in disease. Although extensive studies have been 
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FigUre 11 | P. aeruginosa-induced neTosis results in complement activation on neTs via cFP-dependent and -independent mechanisms. Neutrophils 
were activated with P. aeruginosa PAKgfp MOI 100 [(e–h); green] to induce the formation of NETs [(a–D); blue]. Samples were left in RPMI buffer (left two columns) 
followed by addition of 20% (v/v) autologous plasma in RPMI buffer, or in 20% plasma in AP buffer (AP activation only, right two columns). Samples were 
immunolabeled for C5b–9 [(i–l); red]. Merged images are shown in (M–P). Addition of anti-properdin antibody has no effect on C5b–9 formation in RPMI buffer 
(J,n). Incubation of samples in 20% plasma in AP buffer (AP activation only) with a anti-properdin antibody abolished C5b–9 deposition on NETs (l,P). Images were 
taken with 60×/1.35 oil immersion objective. (M–O) with a 2× magnified insets of a representative area. Scale bar, 9.00 μm.
performed, the exact functions of NETs, and their mechanism 
of action, remain to be completely elicited. NETs have been 
identified in several diseases that are associated with complement 
activation (1, 13, 14, 17, 33). In this study, we sought to under-
stand the involvement of the complement system in the context 
of bacteria and NETs.
The use of varying reagents to induce NETosis has been estab-
lished in many studies (4, 5). Applying these conditions, we found 
that PMA, but not C5a and fMLP, induces NETosis via the produc-
tion of ROS. In order to obtain a more physiological impression of 
the mechanism of NETosis and the interplay with components of 
the complement system, we incorporated the use of P. aeruginosa 
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in further studies. As previously seen (28–30), bacteria are capable 
of inducing Nox-dependent NETosis in a load-dependent manner.
Neutrophils recruited to sites of inflammation are a major 
determinant of AP activation (1). Neutrophil stimulation with 
PMA, C5a, and fMLP resulted in a quick release of the comple-
ment proteins CFP, C3, and CFB. These proteins are critical for the 
assembly of the AP convertase C3bBb, where CFP functions as a 
stabilizer (26). After demonstrating neutrophil release of comple-
ment proteins during NETosis, we confirmed that complement 
proteins became entangled within the NET structures. C5b–9 
was deposited on the NETs, independent of the stimulus (PMA 
and PAKgfp). Deposition was abrogated by the use of DNAse, 
signifying the requirement of the NET lattices for the generation 
of C5b–9. This finding supports a role for NETs in inducing and/
or enhancing complement activation, which is in keeping with 
the recently published observation that NETs can activate and 
deposit complement AP components (25). CFP also binds to 
DNA exposed by necrotic or apoptotic cells, and neutrophil-
secreted CFP has been linked to a positive feedback loop between 
neutrophil and complement activation (1, 34–37). We also found 
CFP deposition on NETs, and the use of an anti-CFP antibody 
blocking the AP allowed us to identify the complement pathways 
involved in NET-mediated C5b–9 activation (38).
Complement factor P blockade was efficient in preventing ter-
minal pathway activation when experimental conditions limited 
complement activation (i.e., C5b–9) on NETs to the AP. When the 
classical and lectin pathways were also allowed to be activated, 
this AP-specific blocking effect was lost. Fluorescence microscopy 
data suggest the possibility of CFP-mediated C5b–9 formation on 
NETs – data consistent with recent studies, indicating that both 
AP- and non-AP-mediated complement activation can occur on 
NETs (1, 5, 25, 37, 39, 40). CFP binding to targets via C3 fragments 
(alone or in context of the C3-/C5-convertases) is also possible.
Taken together, our results demonstrate that the “AP tool 
kit” present in the neutrophils are released upon stimulus, and 
deposits on targets, such as NETs. In the presence of plasma, NET 
formation results in terminal pathway activation via both CFP-
dependent and -independent mechanisms. In NET-mediated 
diseases, the formation of NETs might trigger complement acti-
vation and exert secondary effects, such as cell injury and death. 
This is of great importance, as therapeutic complement inhibitors 
(e.g., eculizumab) are now available for clinical use (41, 42).
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FigUre s1 | PMa and fMlP, but not c5a, induce rOs production in 
neutrophils. Neutrophils were activated with (a) C5a (1 or 2 μM), (B) fMLP  
(1 or 2 μM), and (c) PMA (20 nM) and analyzed by flow cytometry for oxidative 
burst using dihydrorhodamine (DHR) 123. A significant ROS production was 
only observed for fMLP (1 μM) and PMA (20 nM). Results are given as median 
fluorescence intensity (MFI) from three independent experiments. Student’s t-test, 
*p < 0.01.
FigUre s2 | confocal images showing PMa-mediated kinetics of neTosis. 
Neutrophils were activated with PMA (20 nM) to induce NET formation. Samples 
were fixed with 4% (w/v) paraformaldehyde and stained with DAPI for microscopy. 
(a) Four distinct nuclear morphologies (lobulated, delobulated, decondensed 
nuclei; NETs) can be identified during NETosis. (B) Percentage difference for 
nuclear morphologies was identified through manual counting of at least 118–220 
cells from five different focal planes at 40× magnification. Data are presented as 
mean ± SEM from three independent experiments. Statistical significance is shown 
only if percentage of nuclear morphology is significantly different compared to all 
other morphologies at the same time point. Two-way ANOVA with Tukey’s multiple 
comparison test, *p < 0.05, #p < 0.001, $p < 0.0001.
FigUre s3 | anti-cFP antibody concentrations of >4 μg/ml block 
aP-mediated complement activation. Serial dilutions of a mouse monoclonal 
anti-properdin antibody were performed to determine the antibody concentration 
required to completely inhibit complement AP as determined by rabbit 
erythrocyte lysis. This was achieved using concentrations >4 μg/ml. Data are 
presented as mean ± SEM from three independent experiments. Student’s t-test, 
*p < 0.05, **p < 0.01.
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